Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MCCORMICK & CO INC Director's Dealing 2024

Dec 4, 2024

30330_dirs_2024-12-04_8e966cb1-7a88-4be6-801f-57e4f459f130.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MCCORMICK & CO INC (MKC)
CIK: 0000063754
Period of Report: 2024-12-01

Reporting Person: Gabriel Marcos Mendes (Executive VP & CFO)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock - Voting 7362 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Options - Right to Buy $73.6950 2029-03-27 Common Stock - Voting (1092) Direct
Options - Right to Buy $69.3100 2030-04-01 Common Stock - Voting (2264) Direct
Options - Right to Buy $89.16 2031-03-31 Common Stock - Voting (3064) Direct
Options - Right to Buy $97.26 2032-03-30 Common Stock - Voting (2541) Direct
Options - Right to Buy $81.79 2033-03-29 Common Stock - Voting (2907) Direct
Options - Right to Buy $76.0300 2034-03-27 Common Stock - Voting (7330) Direct
Options - Right to Buy $93.49 2030-11-30 Common Stock - Voting (23950) Direct
Restricted Stock Units $0 2025-03-30 Common Stock - Voting (200) Direct
Restricted Stock Units $0 2026-03-29 Common Stock - Voting (480) Direct
Restricted Stock Units $0 2027-03-27 Common Stock - Voting (1889) Direct

Footnotes

F1: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries.

F2: The option grant vests after the third anniversary date and is only exercisable if certain stock price performance requirements are met. The performance requirements are an increase in the common stock non-voting price of 60% for 1/3 of the options, an increase in the common stock non-voting price of 80% for 1/3 of the options, and an increase in the common stock non-voting price of 100% for 1/3 of the options, in each case within five years of the grant date. Both the vesting date and performance requirements must be met for the portion of the grant to become exercisable.

F3: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2023, March 15, 2024 and March 15, 2025.

F4: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2024, March 15, 2025 and March 15, 2026.

F5: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2025, March 15, 2026 and March 15, 2027.